Glucometabolic Control and Anti-Transglutaminase Antibodies at Celiac Disease Onset in Type 1 Diabetes Youth - Poll - MDSpire

Glucometabolic Control and Anti-Transglutaminase Antibodies at Celiac Disease Onset in Type 1 Diabetes Youth

  • By

  • Francesca Di Candia

  • Francesco Maria Rosanio

  • Roberto Franceschi

  • Alessandro Fierro

  • Riccardo Bonfanti

  • Francesca Cardella

  • Valentino Cherubini

  • Giuseppe D’Annunzio

  • Barbara Felappi

  • Dario Iafusco

  • Brunella Iovane

  • Claudio Maffeis

  • Giulio Maltoni

  • Francesca Olivieri

  • Gabriele Olivieri

  • Barbara Piccini

  • Elvira Piccinno

  • Barbara Predieri

  • Ivana Rabbone

  • Maria Rossella Ricciardi

  • Giuseppina Salzano

  • Riccardo Schiaffini

  • Gianluca Tornese

  • Angela Zanfardino

  • Marco Marigliano

  • Riccardo Troncone

  • Riccardo Pertile

  • Luigi Greco

  • Renata Auricchio

  • Enza Mozzillo

  • ISPED Diabetes Study Group Collaborators

  • Francesco Gallo

  • Caterina Grosso

  • Carlo Ripoli

  • Fiorella De Berardinis

  • Susanna Coccoli

  • Valentina Tiberi

  • Sonia Toni

  • Maurizio Delvecchio

  • Rosanna Roppolo

  • Fortunato Lombardo

  • Stefano Passanisi

  • Bruno Bombaci

  • Alberto Casertano

  • Nicola Minuto

  • Marta Bassi

  • Evelina Maines

  • Silvia Savastio

  • Elena Inzaghi

  • Andrea Rigamonti

  • Giulio Frontino

  • Patrizia Bruzzi

  • Claudia Piona

  • November 4, 2025

  • 0 min

Share

Original Source(s)

Glucometabolic Control and Anti-Transglutaminase Antibodies at Celiac Disease Onset in Type 1 Diabetes Youth

  • by Francesca Di Candia, Francesco Maria Rosanio, Roberto Franceschi, Alessandro Fierro, Riccardo Bonfanti, Francesca Cardella, Valentino Cherubini, Giuseppe D’Annunzio, Barbara Felappi, Dario Iafusco, Brunella Iovane, Claudio Maffeis, Giulio Maltoni, Francesca Olivieri, Gabriele Olivieri, Barbara Piccini, Elvira Piccinno, Barbara Predieri, Ivana Rabbone, Maria Rossella Ricciardi, Giuseppina Salzano, Riccardo Schiaffini, Gianluca Tornese, Angela Zanfardino, Marco Marigliano, Riccardo Troncone, Riccardo Pertile, Luigi Greco, Renata Auricchio, Enza Mozzillo, ISPED Diabetes Study Group Collaborators, Francesco Gallo, Caterina Grosso, Carlo Ripoli, Fiorella De Berardinis, Susanna Coccoli, Valentina Tiberi, Sonia Toni, Maurizio Delvecchio, Rosanna Roppolo, Fortunato Lombardo, Stefano Passanisi, Bruno Bombaci, Alberto Casertano, Nicola Minuto, Marta Bassi, Evelina Maines, Silvia Savastio, Elena Inzaghi, Andrea Rigamonti, Giulio Frontino, Patrizia Bruzzi, Claudia Piona

  • November 4, 2025

Related Content

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

Could Wegovy Raise Optic Nerve Risk?

A pharmacovigilance analysis of FDA adverse event reports finds the strongest ischemic optic neuropathy reporting signal with high-dose semaglutide formulations, with higher adjusted odds reported in men.

Does Metabolic and Bariatric Surgery Reduce the Risk of Developing Parkinson’s Disease: A Propensity Score Matching Analysis Using Data from the National Inpatient Sample